Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation
Left Ventricular Outflow Tract (LVOT) obstruction occurs in approximately 70% of Hypertrophic Cardiomyopathy (HCM) patients and currently requires imaging or invasive testing for diagnosis, sometimes in conjunction with provocative physiological or pharmaceutical stimuli. To identify potential bioma...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2474 |
id |
doaj-45a1d431057c4908bdad718d39529696 |
---|---|
record_format |
Article |
spelling |
doaj-45a1d431057c4908bdad718d395296962021-03-02T00:01:59ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01222474247410.3390/ijms22052474Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic InflammationAmy Larson0Towia A. Libermann1Heather Bowditch2Gaurav Das3Nikolaos Diakos4Gordon S. Huggins5Hassan Rastegar6Frederick Y. Chen7Ethan J. Rowin8Martin S. Maron9Michael T. Chin10Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USAGenomics, Proteomics, Bioinformatics and Systems Biology Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USAMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USAMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USACardioVascular Center, Tufts Medical Center, Boston, MA 02111, USAMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USACardioVascular Center, Tufts Medical Center, Boston, MA 02111, USACardioVascular Center, Tufts Medical Center, Boston, MA 02111, USACardioVascular Center, Tufts Medical Center, Boston, MA 02111, USACardioVascular Center, Tufts Medical Center, Boston, MA 02111, USAMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USALeft Ventricular Outflow Tract (LVOT) obstruction occurs in approximately 70% of Hypertrophic Cardiomyopathy (HCM) patients and currently requires imaging or invasive testing for diagnosis, sometimes in conjunction with provocative physiological or pharmaceutical stimuli. To identify potential biomarkers of LVOT obstruction, we performed proteomics profiling of 1305 plasma proteins in 12 HCM patients with documented LVOT obstruction, referred for surgical myectomy. Plasma was collected at the surgical preoperative visit, approximately one month prior to surgery and then at the post-surgical visit, approximately 3 months later. Proteomic profiles were generated using the aptamer-based SOMAscan assay. Principal Component Analysis using the highest statistically significant proteins separated all preoperative samples from all postoperative samples. Further analysis revealed a set of 25 proteins that distinguished the preoperative and postoperative states with a paired <i>t</i>-test <i>p</i>-value of <0.01. Ingenuity Pathway analysis facilitated the generation of protein interaction networks and the elucidation of key upstream regulators of differentially expressed proteins, such as interferon-γ, TGF-β1, and TNF. Biological pathways affected by surgery included organ inflammation, migration, and motility of leukocytes, fibrosis, vasculogenesis, angiogenesis, acute coronary events, endothelial proliferation, eicosanoid metabolism, calcium flux, apoptosis, and morphology of the cardiovascular system. Our results indicate that surgical relief of dynamic outflow tract obstruction in HCM patients is associated with unique alterations in plasma proteomic profiles that likely reflect improvement in organ inflammation and physiological function.https://www.mdpi.com/1422-0067/22/5/2474hypertrophic cardiomyopathyproteomicsaptamercardiovascular diseasemyectomy surgery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amy Larson Towia A. Libermann Heather Bowditch Gaurav Das Nikolaos Diakos Gordon S. Huggins Hassan Rastegar Frederick Y. Chen Ethan J. Rowin Martin S. Maron Michael T. Chin |
spellingShingle |
Amy Larson Towia A. Libermann Heather Bowditch Gaurav Das Nikolaos Diakos Gordon S. Huggins Hassan Rastegar Frederick Y. Chen Ethan J. Rowin Martin S. Maron Michael T. Chin Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation International Journal of Molecular Sciences hypertrophic cardiomyopathy proteomics aptamer cardiovascular disease myectomy surgery |
author_facet |
Amy Larson Towia A. Libermann Heather Bowditch Gaurav Das Nikolaos Diakos Gordon S. Huggins Hassan Rastegar Frederick Y. Chen Ethan J. Rowin Martin S. Maron Michael T. Chin |
author_sort |
Amy Larson |
title |
Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation |
title_short |
Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation |
title_full |
Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation |
title_fullStr |
Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation |
title_full_unstemmed |
Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation |
title_sort |
plasma proteomic profiling in hypertrophic cardiomyopathy patients before and after surgical myectomy reveals post-procedural reduction in systemic inflammation |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-03-01 |
description |
Left Ventricular Outflow Tract (LVOT) obstruction occurs in approximately 70% of Hypertrophic Cardiomyopathy (HCM) patients and currently requires imaging or invasive testing for diagnosis, sometimes in conjunction with provocative physiological or pharmaceutical stimuli. To identify potential biomarkers of LVOT obstruction, we performed proteomics profiling of 1305 plasma proteins in 12 HCM patients with documented LVOT obstruction, referred for surgical myectomy. Plasma was collected at the surgical preoperative visit, approximately one month prior to surgery and then at the post-surgical visit, approximately 3 months later. Proteomic profiles were generated using the aptamer-based SOMAscan assay. Principal Component Analysis using the highest statistically significant proteins separated all preoperative samples from all postoperative samples. Further analysis revealed a set of 25 proteins that distinguished the preoperative and postoperative states with a paired <i>t</i>-test <i>p</i>-value of <0.01. Ingenuity Pathway analysis facilitated the generation of protein interaction networks and the elucidation of key upstream regulators of differentially expressed proteins, such as interferon-γ, TGF-β1, and TNF. Biological pathways affected by surgery included organ inflammation, migration, and motility of leukocytes, fibrosis, vasculogenesis, angiogenesis, acute coronary events, endothelial proliferation, eicosanoid metabolism, calcium flux, apoptosis, and morphology of the cardiovascular system. Our results indicate that surgical relief of dynamic outflow tract obstruction in HCM patients is associated with unique alterations in plasma proteomic profiles that likely reflect improvement in organ inflammation and physiological function. |
topic |
hypertrophic cardiomyopathy proteomics aptamer cardiovascular disease myectomy surgery |
url |
https://www.mdpi.com/1422-0067/22/5/2474 |
work_keys_str_mv |
AT amylarson plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT towiaalibermann plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT heatherbowditch plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT gauravdas plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT nikolaosdiakos plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT gordonshuggins plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT hassanrastegar plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT frederickychen plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT ethanjrowin plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT martinsmaron plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation AT michaeltchin plasmaproteomicprofilinginhypertrophiccardiomyopathypatientsbeforeandaftersurgicalmyectomyrevealspostproceduralreductioninsystemicinflammation |
_version_ |
1724245546555670528 |